...
首页> 外文期刊>Oncology: International Journal of Cancer Research and Treatment >Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
【24h】

Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.

机译:分类树和神经网络算法在血清学肝标志物谱鉴定中的应用,以诊断肝细胞癌。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Although many attempts have been made to identify tumour-specific alpha-fetoprotein (AFP) glycoforms or other serological markers for the diagnosis of hepatocellular carcinoma (HCC), none of the available markers has, so far, shown satisfactory sensitivity and specificity. Here we aimed to apply classification tree and neural network algorithms to interpret the levels of multiple serological liver markers to improve overall specificity and sensitivity, particularly with a view to discriminating between liver cirrhosis with and without HCC. METHODS: We developed classification trees and neural networks that identified serological liver marker profiles comprising AFP, alpha1-antitrypsin (A1AT), alpha2-macroglobulin (A2MG), thyroxine-binding globulin (TBG), transferrin and albumin as well as sex and age, which might permit the diagnosis of HCC. Data were collected from 65 HCC patients, 51 patients with liver cirrhosis alone (LC) and 51 normal healthy subjects. RESULTS: The generated classification trees and neural networks showed similar diagnostic values in differentiating HCC from LC. The classification trees identified AFP, A1AT and albumin as the most important classification parameters, whereas the neural networks identified A2MG, AFP, A1AT and albumin as the predominant factors. The classification logic of the classification trees indicated that more HCC cases could be identified among cases with slightly elevated AFP levels by using the serum levels of A1AT and albumin. The neural networks were also useful for the identification of the HCC cases when the AFP levels were below 500 ng/ml (p < 0.005). The neural networks could identify HCC cases with AFP levels within the normal range, but the classification trees could not. By combining the conventional AFP test and the neural networks, the overall diagnostic sensitivity for HCC was significantly increased from 60.0 to 73.8% (p < 0.05) while maintaining a high specificity (88.2%). The sensitivities for tumors of different sizes were similar. CONCLUSION: The neural network algorithm appeared to be more powerful than the classification tree algorithm in the identification of the distinctive serological liver marker profiles for the diagnosis of the HCC subgroup without significant elevation in serum AFP levels. By incorporating serological levels of other liver markers and including data from a large number of patients and control subjects, it should prove possible to develop a versatile neural network for early diagnosis of HCC. Copyright 2001 S. Karger AG, Basel
机译:目的:尽管人们已经进行了许多尝试来鉴定肿瘤特异性的甲胎蛋白(AFP)糖型或其他血清学标志物,以诊断肝细胞癌(HCC),但到目前为止,没有一种可用的标志物显示出令人满意的敏感性和特异性。在这里,我们旨在应用分类树和神经网络算法来解释多种血清学肝标记物的水平,以提高总体特异性和敏感性,特别是为了区分有和没有HCC的肝硬化。方法:我们开发了分类树和神经网络,可识别血清学肝标志物谱,包括AFP,α1-抗胰蛋白酶(A1AT),α2-巨球蛋白(A2MG),甲状腺素结合球蛋白(TBG),转铁蛋白和白蛋白,以及性别和年龄,这可能可以诊断出肝癌。数据收集自65例HCC患者,51例单纯肝硬化(LC)患者和51例正常健康受试者。结果:生成的分类树和神经网络在区分HCC和LC中显示出相似的诊断价值。分类树将AFP,A1AT和白蛋白确定为最重要的分类参数,而神经网络将A2MG,AFP,A1AT和白蛋白确定为主要因素。分类树的分类逻辑表明,通过使用血清A1AT和白蛋白水平,可以在AFP水平稍高的病例中发现更多的HCC病例。当AFP水平低于500 ng / ml(p <0.005)时,神经网络也可用于鉴定HCC病例。神经网络可以识别AFP水平在正常范围内的HCC病例,但分类树不能。通过将常规AFP测试与神经网络相结合,对HCC的总体诊断敏感性从60.0显着提高至73.8%(p <0.05),同时保持了高特异性(88.2%)。不同大小的肿瘤的敏感性相似。结论:神经网络算法似乎比分类树算法更强大,可以识别出独特的血清学肝标志物,用于诊断HCC亚群而血清AFP水平没有明显升高。通过结合其他肝脏标志物的血清学水平并包括来自大量患者和对照受试者的数据,应该证明有可能开发一种多功能的神经网络,用于HCC的早期诊断。版权所有2001 S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号